[A case of ovarian serous papillary adenocarcinoma combined with malignant endosalpingiosis]. 1993

H Mizutani, and H Katabuchi, and M Nakamura, and K Matsuura, and M Ito, and H Okamura
Department of Obstetrics and Gynecology, Kumamoto University School of Medicine.

UI MeSH Term Description Entries
D007044 Hysterectomy Excision of the uterus. Hysterectomies
D008197 Lymph Node Excision Surgical excision of one or more lymph nodes. Its most common use is in cancer surgery. (From Dorland, 28th ed, p966) Lymph Node Dissection,Lymphadenectomy,Dissection, Lymph Node,Dissections, Lymph Node,Excision, Lymph Node,Excisions, Lymph Node,Lymph Node Dissections,Lymph Node Excisions,Lymphadenectomies,Node Dissection, Lymph,Node Dissections, Lymph
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D002828 Choristoma A mass of histologically normal tissue present in an abnormal location. Aberrant Tissue,Ectopic Tissue,Heterotopic Tissue,Aberrant Tissues,Choristomas,Ectopic Tissues,Heterotopic Tissues,Tissue, Aberrant,Tissue, Ectopic,Tissue, Heterotopic,Tissues, Aberrant,Tissues, Ectopic,Tissues, Heterotopic
D005187 Fallopian Tubes A pair of highly specialized canals extending from the UTERUS to its corresponding OVARY. They provide the means for OVUM transport from the ovaries and they are the site of the ovum's final maturation and FERTILIZATION. The fallopian tube consists of an interstitium, an isthmus, an ampulla, an infundibulum, and fimbriae. Its wall consists of three layers: serous, muscular, and an internal mucosal layer lined with both ciliated and secretory cells. Oviducts, Mammalian,Salpinges, Uterine,Salpinx, Uterine,Uterine Salpinges,Uterine Salpinx,Fallopian Tube,Uterine Tubes,Mammalian Oviduct,Mammalian Oviducts,Oviduct, Mammalian,Tube, Fallopian,Tube, Uterine,Tubes, Fallopian,Tubes, Uterine,Uterine Tube
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D017024 Chemotherapy, Adjuvant Drug therapy given to augment or stimulate some other form of treatment such as surgery or radiation therapy. Adjuvant chemotherapy is commonly used in the therapy of cancer and can be administered before or after the primary treatment. Adjuvant Chemotherapy,Drug Therapy, Adjuvant,Adjuvant Drug Therapy

Related Publications

H Mizutani, and H Katabuchi, and M Nakamura, and K Matsuura, and M Ito, and H Okamura
January 2011, European journal of gynaecological oncology,
H Mizutani, and H Katabuchi, and M Nakamura, and K Matsuura, and M Ito, and H Okamura
September 2006, The Journal of veterinary medical science,
H Mizutani, and H Katabuchi, and M Nakamura, and K Matsuura, and M Ito, and H Okamura
January 1975, Clinical bulletin,
H Mizutani, and H Katabuchi, and M Nakamura, and K Matsuura, and M Ito, and H Okamura
December 1991, Nihon Sanka Fujinka Gakkai zasshi,
H Mizutani, and H Katabuchi, and M Nakamura, and K Matsuura, and M Ito, and H Okamura
August 1962, American journal of obstetrics and gynecology,
H Mizutani, and H Katabuchi, and M Nakamura, and K Matsuura, and M Ito, and H Okamura
March 2009, Gan to kagaku ryoho. Cancer & chemotherapy,
H Mizutani, and H Katabuchi, and M Nakamura, and K Matsuura, and M Ito, and H Okamura
November 2016, Diagnostic cytopathology,
H Mizutani, and H Katabuchi, and M Nakamura, and K Matsuura, and M Ito, and H Okamura
January 1988, Acta cytologica,
H Mizutani, and H Katabuchi, and M Nakamura, and K Matsuura, and M Ito, and H Okamura
October 2010, The American journal of surgical pathology,
H Mizutani, and H Katabuchi, and M Nakamura, and K Matsuura, and M Ito, and H Okamura
January 1988, Acta cytologica,
Copied contents to your clipboard!